Explore more publications!

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on April 2, 2026

More South Africans Are Returning Home After Working Abroad
Stallion Uranium Reports Serious Injury Incident Involving Two Contractors at Moonlite Project
Northern Discovery Metals Inc. Announces Application for Listing on the Canadian Securities Exchange
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026
Fate Therapeutics Reports New Employee Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Century Aluminum Applauds President Trump for Executive Order to Fully Enforce Sec. 232 Aluminum Tariffs
Alumni Express Concern Over Cancellation of Ghanaian President’s Visit and Honorary Degree at Lincoln University
Manhattan Private Credit Launches Network to Connect Investors With Private Credit Markets as Bank Lending Continues to Contract
NIPES Announces Winners of the 2026 Award of Excellence, First Cycle
U2opia launches DCB in Nigeria to help OTTs monetise a prepaid-first market
Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update
Oncotelic Therapeutics Announces Strategic Partnership with TechForce Robotics to Commercialize PDAOAI-Enhanced GMP Robotics Platform
Plato Gold Corp. Announces Sale of Timmins-Area Properties to Mayfair Gold Corp.
Cocrystal Pharma Receives FDA Fast Track Designation for CDI-988 for Norovirus Infection Treatment and Preventive
Refined Energy Completes Maiden Drill Program at Dufferin West, Intersects Unconformity
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer 

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions